DYNAVAX TECHNOLOGIES CORP Business Operations Contracts & Agreements
20 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Indemnification Agreements (1)
- Sales Agreements (2)
- Services Agreements (3)
- Supply Agreements (12)
- Supply Agreement, effective as of September 7, 2023, by and between Company and Nitto Denko Avecia Inc (Filed With SEC on November 2, 2023)
- Amendment No. 3 to Supply Agreement, dated effective as of April 26, 2023, by and between Company and Biological E. Limited (Filed With SEC on August 3, 2023)
- Amendment No. 2 to Supply Agreement, dated effective as of September 30, 2022, by and between the Company and Biological E. Limited (Filed With SEC on November 3, 2022)
- Amendment No. 1 to Supply Agreement, dated effective as of June 23, 2022, by and between the Company and Biological E. Limited (Filed With SEC on November 3, 2022)
- First Amendment to Commercial Manufacturing and Supply Agreement dated September 10, 2021 by and between Baxter Pharmaceutical Solutions LLC and Dynavax Technologies Corporation (Filed With SEC on November 4, 2021)
- Supply Agreement dated July 1, 2021 by and between Company and Biological E. Limited (Filed With SEC on August 4, 2021)
- Supply Agreement dated June 29, 2021 by and among Company, Zhejiang Clover Biopharmaceuticals, Inc., and Clover Biopharmaceuticals (Hong Kong) Co., Limited (Filed With SEC on August 4, 2021)
- Supply Agreement, dated September 11, 2020, by and among the Company, Valneva Scotland Limited and Valneva Austria GmbH (Filed With SEC on November 5, 2020)
- Sales Agreement, dated August 6, 2020, between the Company and Cowen and Company, LLC (Filed With SEC on August 6, 2020)
- Form of Indemnification Agreement (Filed With SEC on November 7, 2019)
- Supply Agreement, dated July 27, 2016, between Company and West Pharmaceutical Services, Inc (Filed With SEC on March 8, 2018)
- Supply Agreement, dated October 1, 2012, between Company and Nitto Denko Avecia, Inc (Filed With SEC on March 8, 2018)
- Supply Agreement, dated November 2, 2016, between Company and Becton, Dickinson and Company (Filed With SEC on March 8, 2018)
- Commercial Manufacturing and Supply Agreement, dated November 22, 2013, between Company and Baxter Pharmaceutical Solutions LLC (Filed With SEC on March 8, 2018)
- First Amendment to Project Agreement, dated October 31, 2017 between Company and inVentiv Commercial Services, LLC (Filed With SEC on March 8, 2018)
- Project Agreement, dated October 31, 2017 between the Company and inVentiv Commercial Services, LLC (Filed With SEC on March 8, 2018)
- Master Services Agreement, dated January 11, 2016, between the Company and inVentiv Commercial Services, LLC (Filed With SEC on March 8, 2018)
- Sales Agreement, dated November 3, 2017, by and between the Company and Cowen and Company, LLC (Filed With SEC on November 3, 2017)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between ASTRAZENECA AB and DYNAVAX TECHNOLOGIES CORPORATION DATE: 1 September 2006 (Filed With SEC on October 31, 2011)
- BETWEEN GLAXO GROUP LIMITED AND DYNAVAX TECHNOLOGIES CORPORATION RESEARCH AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 6, 2009)
